Literature DB >> 33849377

LncRNA PSMG3AS1 promotes proliferation of non-small cell lung cancer cells by sponging miR-613 to upregulate SphK1.

Weiyu Shen1, Xunyu Hong2, Chenghua Jin1, Yong Xi1.   

Abstract

PSMG3-AS1 is a characterized oncogenic lncRNA in breast cancer, while its role in other cancers remains unclear. This study was to investigate the role and underlying mechansim of PSMG3-AS1 in non-small cell lung cancer (NSCLC). In this study, we found that PSMG3-AS1 could interact with miR-613. The expression of PSMG3-AS1 was upregulated in NSCLC, while the expression of miR-613 was downregulated in NSCLC. However, PSMG3-AS1 and miR-613 were not significantly correlated with each other. In NSCLC cells, PSMG3-AS1 and miR-613 overexpression failed to regulate the expression of each other. Interestingly, PSMG3-AS1 overexpression led to upregulated SphK1, a downstream target of miR-613. In addition, PSMG3-AS1 overexpression reduced the inhibitory effects of miR-613 on NSCLC cell proliferation. Therefore, PSMG3-AS1 may promote the proliferation of NSCLC cells by sponging miR-613 to upregulate SphK1.

Entities:  

Keywords:  Non-small cell lung cancer; miR-613; psmg3-as1; sphk1

Mesh：

Substances：

Year:  2021        PMID： 33849377      PMCID： PMC8168623          DOI： 10.1080/15384101.2021.1900499

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


  22 in total

Review 1.  Targeted therapy in non-small-cell lung cancer--is it becoming a reality?

Authors:  Filip Janku; David J Stewart; Razelle Kurzrock
Journal:  Nat Rev Clin Oncol       Date:  2010-06-15       Impact factor: 66.675

Review 2.  Molecular pathology of lung cancer: key to personalized medicine.

Authors:  Liang Cheng; Riley E Alexander; Gregory T Maclennan; Oscar W Cummings; Rodolfo Montironi; Antonio Lopez-Beltran; Harvey M Cramer; Darrell D Davidson; Shaobo Zhang
Journal:  Mod Pathol       Date:  2012-01-27       Impact factor: 7.842

3.  Heterogeneous sphingosine-1-phosphate lyase gene expression and its regulatory mechanism in human lung cancer cell lines.

Authors:  Hiromi Ito; Kayo Yoshida; Masashi Murakami; Kazumi Hagiwara; Noriko Sasaki; Misa Kobayashi; Akira Takagi; Tetsuhito Kojima; Sayaka Sobue; Motoshi Suzuki; Keiko Tamiya-Koizumi; Mitsuhiro Nakamura; Yoshiko Banno; Yoshinori Nozawa; Takashi Murate
Journal:  Biochim Biophys Acta       Date:  2010-12-22

Review 4.  Lung cancer in never smokers: disease characteristics and risk factors.

Authors:  Athanasios G Pallis; Konstantinos N Syrigos
Journal:  Crit Rev Oncol Hematol       Date:  2013-08-04       Impact factor: 6.312

Review 5.  Lung cancer in never smokers--a review.

Authors:  Sébastien Couraud; Gérard Zalcman; Bernard Milleron; Franck Morin; Pierre-Jean Souquet
Journal:  Eur J Cancer       Date:  2012-03-28       Impact factor: 9.162

6.  Atorvastatin partially inhibits the epithelial-mesenchymal transition in A549 cells induced by TGF-β1 by attenuating the upregulation of SphK1.

Authors:  Zhiqiang Fan; Handong Jiang; Zili Wang; Jieming Qu
Journal:  Oncol Rep       Date:  2016-06-22       Impact factor: 3.906

7.  Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer.

Authors:  Libing Song; Huaping Xiong; Jun Li; Wenting Liao; Lan Wang; Jueheng Wu; Mengfeng Li
Journal:  Clin Cancer Res       Date:  2011-02-15       Impact factor: 12.531

Review 8.  The hallmarks of cancer: a long non-coding RNA point of view.

Authors:  Tony Gutschner; Sven Diederichs
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

9.  Sphingosine kinase-1 predicts overall survival outcomes in non-small cell lung cancer patients treated with carboplatin and navelbine.

Authors:  Mariam Gachechiladze; Tomáš Tichý; Vítězslav Kolek; Ivona Grygárková; Jiří Klein; Giorgi Mgebrishvili; Gvantsa Kharaishvili; Mária Janíková; Petra Smičková; Lucia Cierna; Stuart Pitson; Marie-Lise Maddelein; Olivier Cuvillier; Jozef Škarda
Journal:  Oncol Lett       Date:  2019-06-07       Impact factor: 2.967

10.  Lung Cancer Mortality Associated With Smoking and Smoking Cessation Among People Living With HIV in the United States.

Authors:  Krishna P Reddy; Chung Yin Kong; Emily P Hyle; Travis P Baggett; Mingshu Huang; Robert A Parker; A David Paltiel; Elena Losina; Milton C Weinstein; Kenneth A Freedberg; Rochelle P Walensky
Journal:  JAMA Intern Med       Date:  2017-11-01       Impact factor: 44.409
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.